Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001384177 | SCV001583564 | pathogenic | not provided | 2023-08-31 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with TRMU-related conditions. This variant is present in population databases (rs745338284, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Ala268Glufs*3) in the TRMU gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRMU are known to be pathogenic (PMID: 19732863, 23625533). ClinVar contains an entry for this variant (Variation ID: 1071658). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002499800 | SCV002811612 | pathogenic | Aminoglycoside-induced deafness; Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins | 2021-12-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003473951 | SCV004204354 | likely pathogenic | Aminoglycoside-induced deafness | 2023-11-30 | criteria provided, single submitter | clinical testing |